Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,675 signal articles · 41 in last 24h · 156,065 total before filter · latest 1h ago
41last 24h
853last 7d
150● bullish (7d)
86● bearish (7d)
214publishers
AllMacro190Earnings112M&A123Regulatory20Product19Analyst21
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Wheaton’s (WPM) Profits Nearly Doubled While Its Cash Pile Shrank To $100M
Insider Monkey8d agoneutral
Wheaton’s (WPM) Profits Nearly Doubled While Its Cash Pile Shrank To $100M

On August 6, Wheaton Precious Metals (NYSE:WPM) reported second-quarter net earnings of $543 million on $929 million of revenue, both records. Through the first half, net earnings rose 106% to $1.1 billion. During the quarter, the company also made net upfront cash payments of $4.5 billion relative to mineral stream interests, and it now carries […]

Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks
Simply Wall St.8d agobearish
Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks

Health Catalyst is back in focus after analysts revised fair value from about US$2.10 to roughly US$1.83 per share, which points to a more cautious stance on the stock. Recent research has shifted from earlier optimism with price targets in the US$2 to US$3 range to current levels closer to US$1.80, as analysts weigh execution risks around churn, divestitures and the durability of growth in its health technology offerings. In this article, you will see how these changing targets fit into the...

Is Upgraded EPS Guidance Altering The Investment Case For AngloGold Ashanti (AU)?
Simply Wall St.8d agobullish
Is Upgraded EPS Guidance Altering The Investment Case For AngloGold Ashanti (AU)?

In recent days, AngloGold Ashanti has attracted attention as analysts projected a very large year-over-year increase in quarterly earnings per share alongside solid revenue growth, supported by updated consensus estimates. A key insight is that these upward earnings revisions, reflected in the company’s current Zacks Rank of #3 (Hold), highlight growing confidence in AngloGold Ashanti’s near-term profitability without changing its overall rating. We’ll now examine how this recent wave of...

Ascendis Pharma (ASND) Regains Exclusive Rights To Key TransCon Metabolic Programs
Simply Wall St.8d agoneutral
Ascendis Pharma (ASND) Regains Exclusive Rights To Key TransCon Metabolic Programs

Ascendis Pharma (NasdaqGS:ASND) has regained exclusive rights to TransCon technology-based products in metabolic and cardiovascular diseases after ending its collaboration with Novo Nordisk. The company plans to advance its own programs in obesity and type 2 diabetes using its TransCon platform. Management highlighted once-monthly TransCon Semaglutide as a planned program within its expanded metabolic disease pipeline. The regained TransCon metabolic and cardiovascular rights and plans for...

Blackstone (BX) Could Be 13% Undervalued On PGP Glass Exit Talks
Simply Wall St.8d agoneutral
Blackstone (BX) Could Be 13% Undervalued On PGP Glass Exit Talks

Blackstone (BX) is back in focus after reports that Brookfield Corporation is in advanced talks to buy PGP Glass for about $1.3b to $1.5b, a deal that could potentially give Blackstone a full exit from the investment. Recent price action shows that momentum around Blackstone has cooled. The stock is down 13.87% based on the 30-day share price return, and year to date the share price return has declined 21.31%. The 1-year total shareholder return is down 30.70%, compared with a 23.64% total...

NIKE (NKE) Adds Alexandre Arnault As Investors Ask If The Turnaround Is Already Priced In
Simply Wall St.8d agoneutral
NIKE (NKE) Adds Alexandre Arnault As Investors Ask If The Turnaround Is Already Priced In

Nike (NKE) just made a high profile boardroom move. The athletic giant expanded its board to twelve directors and added Alexandre Arnault from LVMH, even as it works through a difficult business reset. NIKE’s boardroom refresh comes at a challenging time, with the share price at US$35.51 after falling about 13.5% over the past 30 days and dropping 43.9% year to date. The 1 year total shareholder return is down 48.3% and the 5 year total shareholder return has declined 74.0%, pointing to...

Trade Desk (TTD) Expands Healthcare Data Ties, Is The Stock Still Undervalued?
Simply Wall St.8d agoneutral
Trade Desk (TTD) Expands Healthcare Data Ties, Is The Stock Still Undervalued?

Trade Desk’s healthcare data push Trade Desk (TTD) is back in focus after expanding its integrations with healthcare data specialists Veeva Systems and IQVIA, giving pharma advertisers more granular campaign insights directly inside its advertising platform. Recent trading has been rough for Trade Desk, with the share price down 24.8% over the past 90 days and the year-to-date share price return declining 63.1%, while the 1-year total shareholder return is down 68.7%. This points to fading...

Investing.com8d agoneutral
How AI concerns moved to the center of the midterm debate

Investing.com -- Artificial intelligence infrastructure has become a politically charged issue ahead of the November U.S. midterm elections, but growing opposition to data centers has yet to materially weaken the construction pipeline, according to Citi.